Report Overview: The Global Organs on Chips Market achieved a valuation of $35.78 Million in 2022 and is anticipated to exceed $254.69 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 27.8% during the forecast period from 2024 to 2032. Key Market Players: Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), Ascendance Bio (US), CN Bio (UK), TissUse...